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Abstract
The signiﬁcance of the chronicled role of the yeast transcription factor Adr1p in
regulating ETR1 was examined in wild type and isogenic adr1D mutant cells. An
ETR1-lacZ reporter construct was used to verify Adr1p-dependent gene expres-
sion. On solid glycerol medium containing X-gal, wild-type cells expressing the
reporter turned blue, whereas the adr1D mutants remained white. b-Galactosidase
activity measurements following 24-h cell growth in liquid glycerol medium
revealed a 6.5-fold greater expression level of the reporter gene in the wild type
compared with the adr1D mutant. In contrast, immunoblotting showed that Etr1p
abundance was essentially indistinguishable between the two strains whereas
Cta1p, whose expression depends on Adr1p, was present in the wild-type cells,
but not in the mutants. Moreover, enzyme assays conducted on transformed wild-
type and adr1D mutant cells expressing a plasmid-borne ETR1 tethered behind the
native promoter revealed similar levels of reductase activity, and the lipoic acid
content in the two parental strains was equivalent. Hence, while Adr1p inﬂuenced
the transcription levels of ETR1, it did not alter the abundance of Etr1p, the levelof
reductase activity, or the cellular amount of lipoic acid. The results point toward a
potentially novel layer of control for maintaining physiological levels of lipoic acid.
Introduction
De novo fatty acid biosynthesis is a spiral process in which
the nascent hydrocarbon chain is extended by two carbons
per turn. Two types of eukaryotic fatty acid synthases (FAS)
can undertake this procedure, their classiﬁcation depending
on the organization of their respective structures. In the
associative type 1 system (FASI), the enzyme activities are
represented by domains on a single cytoplasmic synthase,
whereas in the compartmentalized type 2 system (FASII),
each of these activities is dissociated into discrete proteins.
FASII has been regarded as typically prokaryotic, with the
Escherichia coli process having been described in detail (Rock
& Cronan, 1996; White et al., 2005). On the other hand, the
existence of mitochondrial FASII in Saccharomyces cerevisiae
is a relatively recent discovery (Hiltunen et al., 2005).
The precise product(s) of yeast mitochondrial FASII,
other than lipoic acid, have not yet been positively identiﬁed,
but it is now clear that a functional FASII is critical for the
physiological activity of the organelle. A lesion in any one of
the genes encoding FASII proteins results in respiratory
deﬁciency; mutant cells fail to grow on nonfermentable
carbon sources, contain only small mitochondria, and do
not form cytochrome complexes or produce lipoic acid.
Although all of the yeast FASII genes have been revealed
(Hiltunen et al., 2005), including ETR1 (Torkko et al., 2001),
not much is known about their transcriptional regulation.
The ETR1 promoter controlling the expression of 2-
trans-enoyl-ACP reductase Etr1p contains a nucleotide
sequence situated 91bp upstream of the ATG triplet for the
translational start codon, which is almost identical to the
consensus sequence for an Adr1p-binding site (Young et al.,
2003), termed type 1 upstream activation sequence UAS1,
i.e. CYCCR(A/T/G)N4–36(T/A/C)YGGRG (Cheng et al.,
1994). DNA microarray analysis performed previously on
cells grown under derepressing conditions revealed that the
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Sexpression of 108 genes, among them ETR1, is signiﬁcantly
decreased in the absence of Adr1p (Young et al., 2003).
Moreover, it was shown that the ETR1 promoter contains a
functional UAS1 that complexes with the cognate transcrip-
tion factor in vivo (Young et al., 2003). Here, the extent of
the inﬂuence exerted by Adr1p on ETR1 was scrutinized in
wild-type and adr1D mutant cells using an ETR1-lacZ
reporter gene, and LacZ expression was monitored in cells
grown on solid and liquid media. The abundance of Etr1p in
wild-type and adr1D mutant cells grown on glycerol med-
ium was investigated by immunoblotting as well as reduc-
tase activity assays, and the effect of deleting ADR1 on lipoic
acid biosynthesis was monitored. The results are discussed
in terms of a putative mechanism restricting the amount of
lipoic acid in the mitochondria of wild-type cells despite the
Adr1p-dependent signal to exit glucose repression.
Materials and methods
Yeast strains and plasmids
Saccharomyces cerevisiae strains and plasmids used are listed
in Table 1. The E. coli strains DH10B and TOP10 F0 were
used for plasmid ampliﬁcations and isolations. Saccharo-
myces cerevisiae strain BJ1991 (Jones, 1977) was described
previously, and strains BY4741 wild type and BY4741adr1D
were acquired from EUROSCARF (http://web.uni-frankfurt.
de/). The plasmid vectors used, YCplac22, YCplac33, and
YEplac195, are described (Gietz & Sugino, 1988). Plasmid
YCp173 represented a YCplac33 centromeric vector carrying
the nucleotide sequence for lacZ corresponding to E. coli
b-galactosidase driven by 975 nucleotides of the ETR1
(MRF10) promoter and will be described elsewhere. Plasmid
YEplac195–MRF10 expressing ETR1 behind the native promo-
ter on a URA3-marked multicopy vector was constructed by
applying PCR to yeast genomic DNA using oligonucleotides
that ampliﬁed the ETR1 gene with additional 0.97kb up-
stream and 0.32kb downstream sequences, and inserting the
amplicon into a HindIII- and BamHI-digested YEplac195
vector. A similar strategy was used to generate the low-copy
centromeric plasmid YCplac22-MRF10. Plasmids were in-
troduced into yeast cells using a published method (Chen
et al., 1992).
Media and growth conditions
Standard yeast (Rose et al., 1990) and E. coli (Sambrook
et al., 1989) media were made as described. YPD medium
consisted of 1% (w/v) yeast extract, 2% (w/v) peptone (YP),
2% (w/v) D-glucose, and 2% (w/v) agar. In YPglycerol
medium, glucose was replaced by 3% (w/v) glycerol as the
sole carbon source. Liquid YPD and YPglycerol media were
prepared essentially the same way, except that agar was
omitted. URA3-marked plasmids were maintained in trans-
formed strains using solid synthetic deﬁned SD-Ura med-
ium consisting of a 0.67% (w/v) yeast nitrogen base without
amino acids, 2% (w/v) D-glucose, and 2% (w/v) agar, with
all supplements added, except for uracil (Sigma-Aldrich
Inc., MO). For enzyme assays, cells were grown overnight
in liquid SD-Ura medium lacking agar, transferred to liquid
YPglycerol medium, and cultured for a further 24-h period.
Miscellaneous
The following two procedures were performed according to
published methods: determination of protein concentrations
(Bradford, 1976) and electrophoresis (Laemmli, 1970).
b-Galactosidase activities were determined on solid media
that contained 50mL of 4% (w/v) 5-bromo-4-chloro-3-
indolyl-b-D-galactopyranoside (X-gal), or assayed in soluble
protein extracts that were prepared by breaking cells with
glass beads, and expressed as nanomoles of o–nitrophenyl-b-
D-galactopyranoside (ONPG) hydrolyzed per minute per
Table 1. Saccharomyces cerevisiae strains and plasmids used
Description Sources or references
Strains
BJ1991 MATa leu2 ura3-52 trp1 pep4-3 prb1-122 gal2 Jones (1977)
BJ1991adr1D adr1D::LEU2 Tabak Lab
BY4741 MATa his3D1 leu2D0 met15D0 ura3D0 EUROSCARF
BY4741adr1D ydr216w::kanMX4 EUROSCARF
Plasmids
YCplac22 Yeast low-copy centromeric plasmid vector marked with TRP1 Gietz & Sugino (1988)
YCplac22-MRF10 Loaded with ETR1 ﬂanked by the native promoter and terminator Hiltunen Lab
w
YCplac33 Yeast low-copy centromeric plasmid vector marked with URA3 Gietz & Sugino (1988)
YCp173 YCplac33 loaded with an ETR1-lacZ fusion Hiltunen Lab
YEplac195 Yeast multicopy episomal plasmid vector marked with URA3 Gietz & Sugino (1988)
YEplac195-MRF10 Loaded with ETR1 ﬂanked by the native promoter and terminator Hiltunen Lab
Dr H.F. Tabak, Department of Biochemistry, Academic Medical Center of the University of Amsterdam, the Netherlands.
wDr J.K. Hiltunen, Department of Biochemistry and Biocenter Oulu, University of Oulu, Finland.
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256 A. Gurvitzmilligram of protein (Miller, 1972). The measurements were
conducted over the period of c. 1h. Catalase measurements
were performed as described (Beers & Sizer, 1952), and the
valuesreportedherearetheaverageofthreeexperiments SD.
Whole-cell extracts were prepared according to a published
protocol (Yaffe & Schatz, 1984). Immunoreactive complexes
were visualized using anti-rabbit immunoglobulin G-coupled
horseradish peroxidase in combination with the enhanced
chemiluminescence (ECL) system from Amersham Pharmacia
Biotech. Enoyl reductase activity was assayed spectrophotome-
trically at 231C as described (Dommes & Kunau, 1984). The
assay mixture consisted of 50mM KPi (pH 7.5) and
0.1mgmL
 1 bovine serum albumin, 125mMN A D P H ,a n d
60mM2 - trans-hexenoyl-CoA, which was synthesized via the
mixed anhydride system (Goldman & Vagelos, 1961) as the
substrate. Measurements of lipoic acid using the lipoic acid-
deﬁcient E. coli strain JRG33-lip9 have been described pre-
viously (Herbert & Guest, 1970; Hayden et al., 1993).
Results
Adr1p is necessary for elevated levels of
ETR1-lacZ reporter activity
Previous genome-wide work in combination with chroma-
tin immunoprecipitation demonstrated that Adr1p binds to
the promoter of ETR1 in vivo, and that when propagated
under derepressing conditions in YP medium containing
0.05% glucose, adr1D mutant cells expressed ETR1 3.2-fold
less abundantly than the corresponding wild-type cells
(Young et al., 2003). To examine the dependence of ETR1
expression on Adr1p more closely, an ETR1-lacZ reporter
loaded onto a centromeric plasmid was introduced into
BY4741 wild-type and adr1D mutant cells. Transformants
were grown overnight in liquid SD-Ura for plasmid main-
tenance, and following 10-fold serial dilution (starting with
an A600nm of 1.0) were applied to solid media comprising
YPD or YPglycerol that additionally contained X-gal, and
the plates were incubated at 301C until the colonies turned
blue (Fig. 1a). Although the aforementioned work demon-
strated that cells devoid of Adr1p fail to grow on a synthetic
complete medium containing glycerol, whereas wild-type
cells grow abundantly on this medium, in the present study,
both strains derived from the BY4741 genetic background
grew extensively on YPglycerol. This observation was sig-
niﬁcant because it circumvented possible scenarios whereby
differences in the levels of reporter-gene expression could
have been due to an energy deﬁcit in the mutant strain. In
addition, the present results also conﬁrmed that the wild-
type strain efﬁciently expressed ETR1 on glucose, and even
more abundantly on glycerol, whereas the adr1D mutant
was less efﬁcient because it remained essentially white on
both media (Fig. 1a).
To examine with greater precision the effect of deleting
ADR1 on the expression levels of ETR1 in yeast cells, b-
galactosidase measurements were undertaken using ONPG.
As a control, the Adr1p-regulated CTA1 gene (Simon et al.,
1991; Young et al., 2002) encoding peroxisomal catalase A
was also analyzed. Catalase and b-galactosidase activities
were assayed using soluble protein extracts obtained from
Fig. 1. (a) Expression of an ETR1-lacZ reporter gene on glucose or
glycerol media. Centromeric plasmid YCp173 (Table 1) was introduced
into BY4741 wild-type cells or otherwise isogenic mutants devoid of
Adr1p (adr1D). Tenfold serially diluted cultures ( ) were applied to the
indicated solid media containing X-gal. (b) The effect of the adr1D
deletion on the expression of an ETR1-lacZ reporter gene in cells grown
in liquid glycerol medium. BY4741 wild-type and adr1D mutant cells
harboring YCp173 were grown for 2 days on synthetic glucose medium
lacking uracil (SD-Ura) selecting for plasmid maintenance (0h), and
shifted to a rich glycerol medium (YPglycerol) for 24h. b-Galactosidase
activity was measured in soluble protein extracts, and the values
obtained were as follows: 0h wild type, 14.3; 0h adr1D mutant, 2.4;
24h wild type, 58.1 36.5; 24h adr1D mutant, 9.0 3.9 (mean SD,
n=3). (c) Immunoblotting for the presence of Etr1p and Cta1p in
BY4741 wild-type and adr1D mutant cells. The above extracts were
subjected to 10% (w/v) sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (in duplicate), and resolved proteins were stained with
Coomasie blue for veriﬁcation of equal loading (not shown) or immobi-
lized onto a nitrocellulose membrane. The membrane was incubated
with an anti-Etr1p antibody raised against the homologous protein in
Candida tropicalis, and the signal was visualized using the ECL system
and recorded on an X-ray ﬁlm. The membrane was sequentially washed
and incubated with an anti-Cta1p antibody, and the signal was recorded
as described above.
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257 New insights into ETR1 regulationliquid cultures grown on SD-Ura medium for 2 days,diluted
to an A600nm of 0.2 in YPglycerol medium, and grown for a
further 24-h period. The results of the b-galactosidase
measurements showed that wild-type cells grown on YPgly-
cerol produced 6.5-fold higher levels of the lacZ reporter
compared with the adr1D mutant (Fig. 1b), whereas the
outcome of the control catalase measurements, which
additionally detected residual enzyme activity due to the
Adr1p-independent cytosolic catalase Ctt1p, demonstrated
that on YPglycerol, wild-type extracts gave rise to levels that
were 1.6-fold higher compared with mutant extracts (wild
type; 54 44; adr1D,3 3  14; catalase activity values are
units per mg protein and represent the mean SD, n=3).
Hence, ETR1 transcription depended on Adr1p.
Adr1p does not influence Etr1p abundance in
wild-type cells
To compare the abundance of Etr1p within the two strains,
immunoblotting was performed on the soluble protein
extracts from the previous section. Duplicate gels were used
to resolve the cellular protein contents, and one gel was
stained with Coomasie blue to verify equal protein loading
(not shown), whereas the other was used to transfer the
resolved proteins onto a nitrocellulose membrane. The
membrane was incubated with a primary anti-CtEtr1p anti-
body that was raised in rabbits and directed against the
homologous Etr1p protein in Candida tropicalis. This anti-
body was used previously to label thin sections for ultra-
structural analysis of S. cerevisiae cells overexpressing either
C. tropicalis or S. cerevisiae Etr1p (Torkko et al., 2001).
Following application of the ECL system, the signals were
recorded on an X-ray ﬁlm. The results demonstrated the
presenceof an Etr1p signal of the correct size in the triplicate
samples of each of the two cell types (Fig. 1c; upper panel).
As a positive control, the presence of the aforementioned
Adr1p-dependent Cta1p was also monitored in these sam-
ples. The same membrane was washed clean of the previous
antibody, and a fresh anti-Cta1p antibody was applied. The
results showed that the signal for Cta1p was evident in the
wild type, but was missing from extracts obtained from the
adr1D mutant (Fig. 1c; lower panel). Hence, the results
indicated that unlike the situation with the Cta1p signal,
whose intensity in wild-type extracts was elevated due to
Adr1p, this was not the case with the signal attributable to
Etr1p because the latter’s intensity in the wild type did not
exceed that in the mutant.
Wild-type and adr1D cells contain similar levels
of reductase activities
The observation of equal amounts of Etr1p in both cells
types was unexpected, and so, despite the chronicled speci-
ﬁcity of the antibody for S. cerevisiae Etr1p (Torkko et al.,
2001), a further method for monitoring the levels of this
protein in yeast cells was adopted. Spectrophotometric
enzyme assaysfor 2-trans-enoyl-CoA reductase activityoffer
an attractive alternative to immunoblotting for determining
levels of active enzyme in soluble protein extracts. However,
because native Etr1p levels are too low to be detected in this
assay, a URA3-marked multicopy plasmid YEplac195-
MRF10 (Table 1) was used to amplify the reductase activity.
In this plasmid construct, the gene for Etr1p is ﬂanked by
the native promoter and terminator sequences, and hence
was expected to be expressed similarly to ETR1 at the
genomic locus.
BJ1991 wild type or adr1D mutants were transformed to
uracil prototrophy with YEplac195-MRF10, and following
24-h growth in YPglycerol medium, the cells were harvested
and soluble protein extracts were prepared. Volumes of
0.5-mL protein extracts were mixed into a reaction mixture
consisting of phosphate buffer and NADPH, and following
the addition of 2-trans-hexenoyl-CoA as substrate, the
progress of dinucleotide oxidation was monitored using a
spectrophotometer. The results, expressed in micromoles of
substrate reduced per minute per milligram of protein,
showed that adr1D mutant cells producing Etr1p from the
multicopy plasmid contained an activity of 6.4 2.7
(mean SD, n=3) whereas wild-type extracts gave rise to
an activity level commensurate with 4.4 2.71.5 (mean 
SD, n=3). To emulate more physiological levels of Etr1p
expression, enzyme assays were also conducted on strains
expressing this ETR1 construct from a low-copy centro-
meric plasmid YCplac22-MRF10; however, these strains
produced activities that were below the detection limit of
the assay used. Hence, the absence from an enhanced level
of 2-trans-enoyl-CoA reductase activity in the wild-type
strain correlated with the previous immunoblotting result,
indicating that Etr1p was neither more ample, nor active in
the wild type compared with the situation in the adr1D
mutant.
Ample lipoic acid biosynthesis in wild-type and
adr1D mutant cells
If Etr1p is indeed present to the same extent in both strains,
it follows that lipoic acid biosynthesis would also be
comparable between them. Levels of lipoic acid were deter-
mined (in duplicate) in wild-type and adr1D mutant cells
derived from two genetic backgrounds, BJ1991 and BY4741,
and the values were expressed as nanograms of lipoic acid
per gram wet weight of cells. The assay showed no mean-
ingful difference in the lipoic acid content among the four
strains that were examined (BJ1991 wild type, 236;
BJ1991adr1D, 237; BY4741 wild type, 229; BY4741adr1D,
233). The signiﬁcance of the combined results is discussed
below.
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In the present study, the issue of Etr1p abundance in yeast
cells was approached using three different methods, and this
revealed that despite ETR1 transcription being governed by
Adr1p, at the protein level, Etr1p was not more abundant in
wild-type cells than in those lacking the transcription factor.
The observations made here were (1) immunoblotting failed
to reveal an increased abundance of Etr1p in protein extracts
obtained from veriﬁably derepressed wild-type cells com-
pared with those produced from the adr1D mutant, (2)
reductase assays relying on ectopic Etr1p expression pre-
sumed to obey Adr1p regulation detected similar levels of
enzyme activity in wild-type and adr1D extracts, and (3)
physiological quantities of lipoic acid were comparable
between the wild type and adr1D mutant using two different
strain types. Because of the present results with the ETR1-
lacZ reporter construct, there is no refuting the previous
discovery relating to the in vivo binding of Adr1p to the
ETR1 promoter or the observation that adr1D mutant cells
express ETR1 less abundantly compared with wild-type cells
(Young et al., 2003). However, reasonable doubt has now
been cast as to whether transcriptional regulation exerted by
Adr1p represents the sole – or for that matter – the most
meaningful layer of control over Etr1p abundance in wild-
type cells.
The reason why Etr1p expression is held back in the wild
type is not yet clear. Nevertheless, it is attractive to speculate
that this might be due to the potentiallydeleterious effects of
abnormally high levels of lipoic acid or any other presumed
FASII end products to the integrity of the mitochondrial
compartment. Previous nonphysiological ampliﬁcation of
Etr1p levels obtained by tethering ETR1 to the promoter of
the oleic acid-inducible gene CTA1 and growing cells on
oleic acid resulted in yeast mitochondria that were both
fewer in number and larger in size (Torkko et al., 2001).
Thus, it would be interesting to determine whether this
mitochondrial abnormality would also be reproducible in
cells hosting the aforementioned plasmid expressing ETR1
ﬁtted between the native promoter and terminator se-
quences. A feature of Etr1p that has hitherto remained
underappreciated is that it is also a nuclear protein that
preferentially binds to the T-rich strand forming the core of
the autonomous replication sequence (Yamazoe et al.,
1994). Hence, the inherent possibility of regulation by Etr1p
of its own translation must be considered in future work.
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